This summary was created by AI, based on 1 opinions in the last 12 months.
The experts have varying opinions on the Evolve FANGMA Index ETF (TECH-T). While it has been a strong performer this year, there are concerns about its future performance in 2022. Some experts believe the stock may have reached an extended price to sales ratio, making it a less desirable entry point. There is an expectation of rotation to better risk/reward areas, indicating a potential shift in market sentiment towards this stock. Overall, it seems that the stock's performance and entry point are key areas of concern for the experts.
Very good question. He always insists on his investments being liquid. He has no interest in anything that he can't sell in 10 minutes.
ETF market is so dominated by BlackRock, BMO, and Vanguard, everyone is squabbling over the remaining 15% of the market. So you end up with a lot of nichey products. Evolve has a number of very small ETFs. Adds an element of doubt, so he avoids them. It may be unfair, but he's dealing with retirees who don't need anything that's not liquid.
Evolve FANGMA Index ETF is a Canadian stock, trading under the symbol TECH-T on the Toronto Stock Exchange (TECH-CT). It is usually referred to as TSX:TECH or TECH-T
In the last year, 1 stock analyst published opinions about TECH-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Evolve FANGMA Index ETF.
Evolve FANGMA Index ETF was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Evolve FANGMA Index ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Evolve FANGMA Index ETF In the last year. It is a trending stock that is worth watching.
On 2024-11-15, Evolve FANGMA Index ETF (TECH-T) stock closed at a price of $16.32.
55 bps expense ratio. Strong performer this year, but not so much in 2022. How much is left in the tank? He owns some of the underlying names, and some names he will own tactically from time to time. With tech, a lot of names are extended on price to sales. Not a good entry point, expects rotation to better risk/reward areas.